Latest News of MASI
Masimo investor claims proxy war win as CEO Kiani fails to retain board seat
By Yahoo! Finance |
2 weeks ago
Activist investor Politan secures a proxy victory at Masimo, gaining majority control of the board with nominees Solomon and Jellison joining existing members Koffey and Brennan. The new board aims to...
Founder vs. activist: A dramatic two-year battle over health-tech firm Masimo comes to a head this week
By Yahoo! Finance |
2 weeks ago
Masimo's CEO, Joe Kiani, faced backlash after acquiring Sound United, leading to a power struggle with activist investor Quentin Koffey. Shareholder activism escalated, with a pivotal board vote appro...
'We called her the vegetable whisperer': a tribute to cook Carla Tomasi
By The Guardian |
2 weeks ago
Carla Tomasi, a beloved Italian chef and teacher, impacted many lives with her passion for food. From hosting lunches to sharing recipes, her influence was profound. Her legacy lives on through the co...
-
Masimo, under activist pressure, subpoenaed two top proxy advisors for private investor communications
By CNBC | 1 month agoMasimo subpoenaed proxy advisors ISS and Glass Lewis for private communications about an upcoming proxy contest with Politan Capital. Masimo founder Joe Kiani, close to President Biden, framed the vot...
-
Masimo Clears Technical Benchmark, Hitting 80-Plus RS Rating
By Investor's Business Daily | 1 month agoLearn how to find the best IPO stocks by using a unique rating system that measures market leadership. Top-performing stocks usually have an RS Rating over 80. Consider factors like risk management, e...
-
Masimo (NASDAQ:MASI) stock falls 6.3% in past week as three-year earnings and shareholder returns continue downward trend
By Yahoo! Finance | 2 months agoMasimo Corporation's stock price has experienced significant declines over the past three years, with shareholders facing losses. The company's earnings per share has also decreased, reflecting invest...
-
AB Science touts positive Phase II Covid-19 data for masitinib
By Yahoo! Finance | 2 months agoAB Science reported positive results from a Phase II trial of masitinib in Covid-19 patients, showing improvement in clinical status when used with isoquercetin. Masitinib, an anti-inflammatory drug, ...
-
AB Science announces positive results of its Phase 2 study evaluating masitinib in Covid-19
By Yahoo! Finance | 2 months agoAB Science reports positive results from Phase 2 study of masitinib in COVID-19 patients. Study showed promising efficacy in improving clinical status with odds ratio of 2.4. Safety profile aligns wit...
-
Masimo (MASI) Fights Politan in a Bid to Retain CEO on Board
By Yahoo! Finance | 3 months agoMasimo and activist investor Politan Capital Management are in a battle over board control, with Politan pushing to replace CEO Joe Kiani. Employees support Kiani, while Masimo accuses Politan of fals...
-
Masimo Corporation (MASI) Stock Price, News, Quote & History - Yahoo Finance
By Yahoo! Finance | 3 months agoMasimo's nominee, Christopher Chavez, brings strong independence and extensive medtech CEO experience to the board. The company warns against electing Politan's nominees to prevent compromising shareh...
-
Masimo activist Politan presents 'last chance' for shareholders to force change at med-tech company
By CNBC | 3 months agoMasimo CEO Joe Kiani spoke at a press conference in Bangalore in 2017. Shareholders' governance concerns at Masimo remain unresolved, as activist investor Politan Capital Management seeks further chan...
-
Botswana's President Masisi Gives Multi-Faceted Diamond Talk At JCK
By Forbes | 3 months agoThe JCK gem and jewelry trade fair, organized by RX, annually attracts industry professionals. President Masisi's talk highlighted Botswana's diamond industry's positive impact on the economy, society...
-
Is Now An Opportune Moment To Examine Masimo Corporation (NASDAQ:MASI)?
By Yahoo! Finance | 3 months agoMasimo Corporation has shown 15% share price growth on NASDAQGS. Despite not reaching yearly highs yet, it's currently undervalued at $218.20, making it a potential buying opportunity with expected pr...